<DOC>
	<DOCNO>NCT00695331</DOCNO>
	<brief_summary>The purpose study compare efficacy safety titrate oral misoprostol solution intravenous oxytocin labor augmentation woman without adequate uterine contraction .</brief_summary>
	<brief_title>Efficacy Safety Study Titrated Oral Misoprostol Solution Labor Augmentation</brief_title>
	<detailed_description>Numerous labor course necessitate augmentation uterine contraction inadequate . When cervix favorable , labor augmentation attempt likely successful . Augmentation woman traditionally undertake intravenous oxytocin amniotomy , either alone combination . In previous trial , proven method titrate oral misoprostol associate low incidence uterine hyperstimulation lower cesarean delivery rate vaginal misoprostol labor induction patient unfavorable cervix . Because administer Misoprostol solution easy cost saving , worth develop novel method labor augmentation .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Pregnancy 36 42 week gestation Live singleton Cephalic presentation A reassuring fetal heart rate pattern Bishop score great 6 Inadequate uterine contraction ( less equal 2 per 10 minute ) Nonreassuring fetal heart rate pattern Parity five Uterine scar Suspected placental abruption abnormal fetal heart rate Vaginal bleeding `` bloody show '' Significant maternal cardiac , renal , hepatic disease hypersensitivity oxytocin , misoprostol prostaglandin analogue</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Labor Augmentation</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>Oxytocin</keyword>
</DOC>